产品名称
咪唑, anhydrous, free-flowing, Redi-Dri™, ACS reagent, ≥99%
Quality Level
grade
ACS reagent, anhydrous
vapor pressure
<1 mmHg ( 20 °C)
product line
Redi-Dri™
assay
≥99%
form
solid
quality
free-flowing
impurities
≤0.2% water
ign. residue
≤0.1%
pH
9.5-11.0 (25 °C, 5% in H2O)
pKa (25 °C)
6.95
bp
256 °C (lit.)
mp
88-91 °C (lit.)
cation traces
Fe: ≤0.001%
SMILES string
c1c[nH]cn1
InChI
1S/C3H4N2/c1-2-5-3-4-1/h1-3H,(H,4,5)
InChI key
RAXXELZNTBOGNW-UHFFFAOYSA-N
Application
咪唑由于具有两性性质和快速的质子转移能力,可作为质子转移试剂用于多孔有机聚合物合成。
咪唑作为催化剂的用途:
咪唑作为催化剂的用途:
- 在氯硅烷/DMF存在下,醇、羧酸和胺类物质的硅烷化反应。
- 羧酸和光气制备相应酰氯。
- 咪唑-PPh3/I2催化体系用于醇变为碘化物的转换反应。
- 咪唑-PPh3/I2用于二醇脱氧反应。
特别适用于 pH 6.2-7.8 范围内的缓冲液
Legal Information
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under 咪唑
signalword
Danger
hcodes
Hazard Classifications
Acute Tox. 4 Oral - Eye Dam. 1 - Repr. 1B - Skin Corr. 1C
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 2
flash_point_f
293.0 °F - closed cup
flash_point_c
145 °C - closed cup
商品
Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.
Joy Rathjen et al.
Reproduction, fertility, and development, 26(5), 703-716 (2013-06-14)
Human embryonic stem (ES) cells have been proposed as a renewable source of pluripotent cells that can be differentiated into various cell types for use in research, drug discovery and in the emerging area of regenerative medicine. Exploitation of this
Joel E Schmidt et al.
Angewandte Chemie (International ed. in English), 53(32), 8372-8374 (2014-06-26)
Crystalline molecular sieves are used in numerous applications, where the properties exploited for each technology are the direct consequence of structural features. New materials are typically discovered by trial and error, and in many cases, organic structure-directing agents (OSDAs) are
E Rosalie Witjas-Paalberends et al.
The Journal of physiology, 592(15), 3257-3272 (2014-06-15)
The first mutation associated with hypertrophic cardiomyopathy (HCM) is the R403Q mutation in the gene encoding β-myosin heavy chain (β-MyHC). R403Q locates in the globular head of myosin (S1), responsible for interaction with actin, and thus motor function of myosin.
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 792527-100G | 04061832950914 |
| 792527-1KG | 04061832950921 |
| 792527-500G | 04061832950938 |


